new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Gilead Sciences Inc patents

Recent patent applications related to Gilead Sciences Inc. Gilead Sciences Inc is listed as an Agent/Assignee. Note: Gilead Sciences Inc may have other listings under different names/spellings. We're not affiliated with Gilead Sciences Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gilead Sciences Inc-related inventors




Date Gilead Sciences Inc patents (updated weekly) - BOOKMARK this page
03/16/17Modulators of toll-like receptors for the treatment of hiv
03/16/17Methods for treating arenaviridae and coronaviridae virus infections
03/02/17Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
03/02/17Solid forms of tenofovir
03/02/17Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
02/16/17Methods for treating hcv
02/09/17Syk inhibitors
02/02/17Pharmaceutical formulations
02/02/17Compounds and methods for antiviral treatment
01/19/17Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
01/12/17Cot modulators and methods of use thereof
01/12/17Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
01/12/17Cot modulators and methods of use thereof
01/05/17Pharmaceutical formulations
12/29/16Treatment of chronic graft versus host disease with syk inhibitors
12/29/16Benzimidazole derivatives as bromodomain inhibitors
12/22/16Syk inhibitors
12/22/16Co-crystals, salts and solid forms of tenofovir alafenamide
12/22/16Therapeutic compounds
12/15/16Methods for treating filoviridae virus infections
12/15/16Inhibitors of hepatitis c virus
12/15/16Antiviral compounds
12/15/16Fused heterocyclic compounds as ion channel modulators
12/08/16Salts of hiv inhibitor compounds
12/01/16Compositions and methods of treating pulmonary hypertension
12/01/16(n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
12/01/16Fused heterocyclic compounds as ion channel modulators
11/24/16Processes and intermediates for preparing anti-hiv agents
11/17/16Therapies for treating cancers
11/17/16Processes for preparing fused heterocyclic ion channel modulators
11/17/16Processes for preparing fused heterocyclic ion channel modulators
11/17/16Benzimidazole and imadazopyridine carboximidamide compounds
11/03/16Fused heterocyclic compounds as ion channel modulators
11/03/16Apoptosis signal-regulating kinase inhibitors
10/27/16Syk inhibitors
10/27/16Methods for preparing anti-viral nucleotide analogs
10/20/16Modulators of pharmacokinetic properties of therapeutics
10/20/16Methods of treating hepatitis b virus
10/06/16Toll like receptor modulator compounds
10/06/16Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
09/29/16Therapies for treating myeloproliferative disorders
09/29/16Solid forms of an ask1 inhibitor
09/08/164,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
09/01/16Quinazoline compounds
09/01/16Fused pyrimidine compounds
08/25/16Processes for preparing ask1 inhibitors
08/18/16Apoptosis signal-regulating kinase inhibitor
08/18/16Pyrazolo[1,5-a]pyrimidines as antiviral agents
08/18/16Isoquinoline compounds
08/04/16Combination therapies for treating cancers
08/04/16Macrocyclic inhibitors of flaviviridae viruses
07/28/16Pharmaceutical compositions of ranolazine and dronedarone
07/07/16Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
06/23/16Hydroxy containing fxr (nr1h4) modulating compounds
06/23/16Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
06/23/16Substituted 1,2,3,4,6,8,12,12a-octahydro-1,4-methanodipyrido[1,2-a:1',2'-d]pyrazines and methods for treating viral infections
06/16/16Methods of treating pulmonary hypertension
06/16/16Combination methods for treating cancers
06/02/16Therapeutic compounds
05/12/16Apoptosis signal-regulating kinase inhibitors
05/12/16Pyrazolo[1,5-a]pyrimidines for antiviral treatment
05/12/16Inhibitors of hepatitis c virus
05/05/16Methods for the preparation of ribosides
05/05/16Methods for treating filoviridae virus infections
04/21/16Therapeutic compounds
Patent Packs
04/21/16Solid forms of a toll-like receptor modulator
04/07/16Tank-binding kinase inhibitor compounds
04/07/16Fused heterocyclic compounds as ion channel modulators
03/24/16Therapeutic compounds
03/24/16Antiviral compounds
03/17/16Benzimidazole derivatives as bromodomain inhibitors
03/17/16Methods of preparing toll-like receptor modulators
03/10/16Therapeutic compounds
03/10/16Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir
03/10/16Modulators of pharmacokinetic properties of therapeutics
03/10/16Modulators of pharmacokinetic properties of therapeutics
03/03/16Syk inhibitors
02/25/162'-chloro aminopyrimidinone and pyrimidine dione nucleosides
02/11/16Phosphatidylinositol 3-kinase inhibitors
02/04/16Benzimidazolone derivatives as bromodomain inhibitors
Patent Packs
01/28/16Phosphatidylinositol 3-kinase inhibitors
01/28/16Therapeutic compounds
01/28/16Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
01/21/16Therapeutic compounds
01/21/16Sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b]oxazepin-8-olate
01/21/16Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
01/14/16Modulators of toll-like receptors for the treatment of hiv
01/07/16Methods and intermediates for preparing pharmaceutical agents
12/24/15Crystalline forms of (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
12/24/15Synthesis of polycyclic-carbamoylpyridone compounds
12/17/15(n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
12/17/15Phosphatidylinositol 3-kinase inhibitors
12/17/15Phosphatidylinositol 3-kinase inhibitors
12/17/15Phosphatidylinositol 3-kinase inhibitors
12/17/15Phosphatidylinositol 3-kinase inhibitors
12/17/15Antiviral compounds
12/17/15Phosphatidylinositol 3-kinase inhibitors
12/17/15Macrocyclic inhibitors of flaviviridae viruses
12/17/15Methods for treating cardiovascular diseases
12/03/15Novel fxr (nr1h4) binding and activity modulating compounds
12/03/15Methods of treating liver disease
12/03/15Tank-binding kinase inhibitor compounds
12/03/15Macrocyclic inhibitors of flaviviridae viruses
11/19/15Fused heterocyclic compounds as ion channel modulators
10/15/15Methods for preparing anti-viral nucleotide analogs
10/08/15Methods of treating patients having implantable cardiac devices
10/08/15Myocardial perfusion imaging methods and compositions
10/01/15Macrocyclic inhibitors of flaviviridae viruses
09/10/15Compounds for the treatment of addiction
09/03/15Apoptosis signal-regulating kinase inhibitors
Social Network Patent Pack
08/27/15Compounds and methods for antiviral treatment
08/27/15Modulators of toll-like receptor 7
08/27/15Fused heterocyclic compounds as ion channel modulators
08/13/15Method for treating a pulmonary hypertension condition
08/13/15Solid forms of an ion channel modulator
08/13/15Processes for preparing fused heterocyclic ion channel modulators
08/13/15Modulators of pharmacokinetic properties of therapeutics
08/06/15Methods of treating patients co-infected with hiv and tuberculosis
07/23/15Processes and intermediates for preparing anti-hiv agents
07/16/15Solid forms of tenofovir
Patent Packs
07/02/15Salts of hiv inhibitor compounds
06/25/15Fused heterocyclic compounds as ion channel modulators
06/25/15Fused heterocyclic compounds as ion channel modulators
06/25/15Apoptosis signal-regulating kinase inhibitors
06/25/15Syk inhibitors
06/25/15Crystalline forms of an antiviral compound
06/25/15Synthesis of an antiviral compound
06/25/15Inhibitors of hepatitis c virus
06/18/15Pyrazolo[1,5-a]pyrimidines as antiviral agents
06/04/15Tablets for combination therapy
06/04/15Methods for treating cancers
06/04/15Methods and compounds for treating paramyxoviridae virus infections
05/28/15Quinoline derivatives as bromodomain inhibitors
05/28/15Therapies for treating myeloproliferative disorders
05/21/15Methods for treating hcv
05/14/15Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
05/07/15Combination therapy for treating pulmonary hypertension
05/07/15Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
04/23/15Methods and compounds for treating paramyxoviridae virus infections
04/23/15Compositions and methods for combination antiviral therapy
04/23/15Compositions and methods for combination antiviral therapy
04/23/15Naphthalene acetic acid derivatives against hiv infection
04/16/15Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
03/19/15Fused heterocyclic compounds as ion channel modulators
03/19/15Antiviral compounds
03/12/15Hcv genotype 4d replicons
03/05/15Process for preparing dronedarone and salts thereof
02/12/15Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
02/12/15Spray dried formulations
02/12/152- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
Patent Packs
02/05/15Pharmaceutical compositions of ranolazine and dronedarone
02/05/15Methods of treating hypertrophic cardiomyopathy
02/05/15Syk inhibitors
02/05/15Compound and methods for treating long qt syndrome
01/22/15Methods of myocardial perfusion imaging
01/22/15Antiviral phosphonate analogs
01/15/15Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
01/15/15Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
01/08/15Modulators of pharmacokinetic properties of therapeutics
01/01/15Pharmaceutical compositions and methods for their preparation
01/01/15Methods and intermediates for preparing pharmaceutical agents
12/25/14Method of treating diabetes
12/18/14Method and composition for pharmaceutical product
12/18/14Phosphatidylinositol 3-kinase inhibitors
12/11/14Methods and intermediates for preparing pharmaceutical agents
11/20/14Method of treating a viral infection using elvitegravir combinations
11/20/14Method of treating a viral infection using elvitegravir combinations
11/13/14Benzimidazole derivatives as bromodomain inhibitors
11/06/14Combination therapy for the treatment of arrhythmias or heart failure
10/30/14Method of treating atrial fibrillation
Social Network Patent Pack
10/16/14Antiviral compounds
10/09/14Fused heterocyclic compounds as ion channel modulators
10/02/14Inhibitors of human immunodeficiency virus replication
10/02/14Benzimidazolone derivatives as bromodomain inhibitors
09/25/14Antiviral compounds
09/18/14Compositions and methods of treating pulmonary hypertension
09/18/14Synthesis of an antiviral compound
08/28/14Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
08/28/14Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists
08/14/14Salts of hiv inhibitor compounds
08/14/14Apoptosis signal-regulating kinase inhibitor
08/14/14Apoptosis signal-regulating kinase inhibitor
08/07/14Therapeutic compounds
08/07/14Therapeutic compounds
08/07/14Viral inhibitors
08/07/14Therapeutic compounds
08/07/14Therapeutic compounds
07/31/14Process for preparing an a2a-adenosine receptor agonist and its polymorphs
07/31/14Compositions and methods for combination antiviral therapy
07/03/14Amorphous solid salts
Social Network Patent Pack
07/03/14Tenofovir alafenamide hemifumarate
06/26/14Apoptosis signal-regulating kinase inhibitors
05/22/14Compounds for the treatment of hiv
05/15/14Dry powder fosfomycin/tobramycin formulation for inhalation
05/15/14Fused heterocyclic compounds as ion channel modulators
05/08/14Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
05/08/14Methods for preparing anti-viral nucleotide analogs
05/01/14Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
04/24/14Antiviral compounds
04/17/14Modulators of pharmacokinetic properties of therapeutics
04/17/14Substituted heterocyclic compounds as ion channel modulators
04/03/14Fused heterocyclic compounds as ion channel modulators
04/03/14Biomarkers for hedgehog inhibitor therapy
03/27/14Anti-ddr1 antibodies
03/27/14Methods and intermediates for preparing pharmaceutical agents
03/13/14Pyrazolo[1,5-a]pyrimidines for antiviral treatment
03/13/14N-pyrazole a2a receptor agonists
02/27/14Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
02/20/14Antiviral compounds
02/20/14Antiviral compounds
02/20/14Compounds for the treatment of addiction
02/20/14Synthesis of an antiviral compound
02/20/14Synthesis of an antiviral compound
02/13/14Benzothiazole compounds and their pharmaceutical use
02/06/14Method and composition for pharmaceutical product
02/06/14Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
02/06/14Antiviral compounds
02/06/14Process and intermediates for preparing integrase inhibitors
01/30/14Inhibitors of flaviviridae viruses
01/30/14Method for treating a pulmonary hypertension condition without companion diagnosis
Social Network Patent Pack
01/23/14Macrocyclic inhibitors of flaviviridae viruses
12/26/13Myocardial perfusion imaging methods and compositions
12/05/13Inhibitors of flaviviridae viruses
12/05/13Substituted heterocyclic compounds
12/05/13Synthesis of antiviral compound
11/28/13Antiviral phosphonate analogs
11/28/13Method of treating atrial fibrillation
11/21/13Inhibitors of cytochrome p450
10/24/13Inhibitors of cytochrome p450
10/24/13Therapeutic compounds
10/24/13Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
10/17/13Methods for treating hcv
10/17/13Inhibitors of cytochrome p450 (cyp3a4)
09/26/13Process and intermediates for preparing integrase inhibitors
09/19/132'-substituted carba-nucleoside analogs for antiviral treatment
09/05/13Aldh-2 inhibitors in the treatment of addiction
08/29/13Method for treating a pulmonary hypertension condition without companion diagnosis
08/29/13Method for treating pulmonary arterial hypertension in a patient not having idiopathic pulmonary fibrosis
08/29/13Method for treating a pulmonary hypertension condition without companion diagnosis
08/15/132-quinolinyl-acetic acid derivatives as hiv antiviral compounds
08/08/13Compounds for the treatment of addiction
08/08/13Napht-2-ylacetic acid derivatives to treat aids
08/08/13Inhibitors of human immunodeficiency virus replication
08/08/13Apoptosis signal-regulating kinase inhibitors
08/01/13Substituted heterocyclic compounds
08/01/13Apoptosis signal-regulating kinase inhibitor
08/01/13Inhibitors of human immunodeficiency virus replication
07/25/13Inhibitors of human immunodeficiency virus replication
07/18/13Fused heterocyclic compounds as ion channel modulators







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gilead Sciences Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gilead Sciences Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';